Welcome to our dedicated page for Braskem Sa SEC filings (Ticker: BAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating feed-stock sensitivities, environmental liabilities, and minority-ownership details inside Braskem鈥檚 sprawling SEC filings can feel like cracking a refinery on your own. The company鈥檚 cross-border operations, commodity pricing swings, and leadership in green polyethylene make its 10-K and 10-Q reports some of the most technically dense in the chemicals sector.
Stock Titan鈥檚 AI turns those hundreds of pages into clear, actionable insight. Want the latest Braskem insider trading Form 4 transactions? We stream them in real-time and flag unusual buying or selling. Need to grasp a Braskem quarterly earnings report 10-Q filing before the market opens? Our machine-learning summaries highlight segment EBITDA, feed-stock spread movements, and sustainability KPIs in minutes. Even unplanned plant shutdowns filed on an 8-K material event are explained plainly鈥攏o industry jargon required.
Every disclosure type is here, updated the instant EDGAR posts it: 10-K annual reports for long-term strategy, 10-Q quarterlies for margin trends, 8-Ks for market-moving events, DEF 14A proxy statements for Braskem executive compensation, and Form 4s for Braskem executive stock transactions. Our platform lets professionals:
- Track Braskem Form 4 insider transactions alongside commodity-cycle shifts
- Compare quarter-over-quarter resin pricing in seconds
- Monitor environmental provision changes without scrolling hundreds of pages
- Export AI-generated highlights for board or client decks
Stop parsing dense petrochemical terminology alone. Stock Titan delivers Braskem SEC filings explained simply, so you can focus on decisions, not documentation.
Customers Bancorp, Inc. (CUBI) filed an amended Form 4 disclosing that Chief Credit Officer Thomas H. Kasulka received an equity grant of 6,893 Restricted Stock Units (RSUs) on 07/09/2025 at a reference price of $63.97 per share. The amendment corrects the initial 07/10/2025 filing, which understated the grant at 3,447 RSUs.
Following the grant, Kasulka鈥檚 direct beneficial ownership stands at 21,808 common shares, comprised of 1,382 shares and 20,426 unvested RSUs. The RSUs vest in three equal annual installments, strengthening management鈥檚 long-term alignment with shareholders but do not represent an open-market purchase.
The filing is administrative鈥攊t adjusts previously mis-reported figures rather than signalling new insider buying or selling. No cash changed hands and there is no impact on the company鈥檚 operations or financial results.
Form 8-K 鈥� Item 8.01 Other Events
On 9 July 2025 the Santa Barbara County Superior Court denied Sable Offshore Corp.鈥檚 (NYSE: SOC) motion to stay the California Coastal Commission鈥檚 10 April 2025 Cease-and-Desist Order that limits maintenance and repair work in the coastal zone. The company filed a Notice of Appeal against the court鈥檚 28 May 2025 preliminary-injunction order and plans to pursue relief in the California Court of Appeal.
Operationally, Sable continues to produce from the Santa Ynez Unit, routing volumes to storage tanks at Las Flores Canyon. Management reiterates its plan to restart the Las Flores Pipeline System and targets first oil sales on 1 August 2025, subject to regulatory approval.
No financial statements, guidance, or earnings metrics accompanied this filing. The forward-looking statements emphasize litigation outcomes, restart timing, regulatory compliance, and other factors cited in prior SEC reports as key risks to future performance.
Braskem S.A. (NYSE: BAK) disclosed that controlling shareholder Novonor and potential buyer Petroqu铆mica Verde FIP have formally notified Brazil鈥檚 antitrust authority (CADE) to seek approval for a possible transfer of Novonor鈥檚 stake held through NSP Investimentos. The filing is an early but necessary step toward a transaction first flagged on May 23, 2025.
The companies emphasize that no binding agreement has yet been signed. Completion remains contingent on (i) CADE clearance, (ii) Novonor鈥檚 compliance with its shareholders-agreement obligations to Petrobras, and (iii) successful negotiations with creditor banks that currently hold fiduciary liens on Novonor鈥檚 Braskem shares. Management provided no financial terms or timeline.
- The move could reshape Braskem鈥檚 ownership structure, potentially easing Novonor鈥檚 financial distress and introducing a new strategic partner.
- However, multiple approvals and creditor negotiations create execution risk and timing uncertainty.
Braskem S.A. (NYSE:BAK) filed a Form 6-K reporting the minutes of its Board of Directors meeting held on 26 June 2025.
- Key action: The Board unanimously elected Mr. Nir Lander as a Statutory Officer (without specific designation) effective 1 July 2025, replacing Mr. Andr茅 Amaro.
- Term: Mr. Lander will serve until the first Board meeting following the 2027 Ordinary General Meeting.
- Governance compliance: The new officer provided all declarations required under Brazilian Corporation Law and CVM Resolutions 44 and 80, confirming no legal impediments.
- Board composition (from 1 July 2025):
- Roberto Prisco Paraiso Ramos 鈥� CEO
- Felipe Montoro Jens 鈥� CFO & IRO
- Stefan Lanna Lepecki 鈥� Director
- Nir Lander 鈥� Director
- Geraldo Magela de Moraes Vila莽a Netto 鈥� Director
No other subjects were recorded, and the meeting was adjourned without additional matters.
FAQ
What is the current stock price of Braskem Sa (BAK)?
What is the market cap of Braskem Sa (BAK)?
What is Braskem SA's core business?
How does Braskem generate its revenue?
Which key markets does Braskem operate in?
What products are central to Braskem's portfolio?
How does Braskem maintain its competitive edge?
What distinguishes Braskem in the production of biopolymers?
How does Braskem adapt to global market dynamics?
How does Braskem compare to its competitors?
